Treatment of vasculitic leg ulcers in connective tissue disease with iloprost

D. J. Veale, A. H. Muir, K. D. Morley, J. J. F. Belch

    Research output: Contribution to journalArticlepeer-review

    21 Citations (Scopus)


    Leg ulcers are a recognised manifestation of cutaneous vasculitis in connective tissue diseases (CTDs) including rheumatoid arthritis (RA). Iloprost a stable prostacyclin analogue has been successfully used to treat Raynaud's phenomenon and digital ulcers associated with CTD's. Our aim was to assess iloprost in the treatment of vasculitic leg ulcers in CTD. In this paper we describe eight cases of vasculitic leg ulceration in association with RA and CTD, treated with intravenous iloprost. The iloprost was administered for 6-8 hours daily and continued for 21-28 days. Immunosuppressive therapy was required in three patients with severe necrotising vasculitis (RAnv). Complete ulcer healing was achieved in four patients within 6 weeks of commencing therapy while rapid improvement occurred in the other four patients. This suggests that iloprost may be useful as an adjunct to therapy for vasculitic leg ulcers. A double-blind placebo controlled study of iloprost therapy for RA leg ulcers is under way.
    Original languageEnglish
    Pages (from-to)187-190
    Number of pages4
    JournalClinical Rheumatology
    Issue number2
    Publication statusPublished - 1995


    Dive into the research topics of 'Treatment of vasculitic leg ulcers in connective tissue disease with iloprost'. Together they form a unique fingerprint.

    Cite this